Food scientist Mary Mulry details the shifting landscape for manufacturers of cannabis edibles and how the shift from the underground to the mainstream requires more science in product development and manufacturing. In addition she discusses how potency on the labels compares across batches as well as to alcohol, and big pharma’s fear about the growing use of weed as an alternative to prescription drugs.